Paxillin anticorps (pTyr31)
Aperçu rapide pour Paxillin anticorps (pTyr31) (ABIN1821310)
Antigène
Voir toutes Paxillin (PXN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- pTyr31
-
Specificité
- Human Paxillin when phosphorylated at Tyr31.
-
Purification
- Affinity purified
-
Immunogène
-
Synthetic phosphopeptide corresponding to human Paxillin Tyr31 site.
Type of Immunogen: Synthetic phospho-peptide -
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Approved: ICC (8 - 25 μg/mL), WB (0.1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Sterile PBS to 0.5 mg/mL.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS, trehalose
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- Paxillin (PXN)
-
Autre désignation
- PXN / Paxillin
-
Sujet
-
Name/Gene ID: PXN
Synonyms: PXN, Paxillin -
ID gène
- 5829
-
UniProt
- P49023
-
Pathways
- Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-